A parliamentary committee has recommended the consolidation of all AYUSH drug-related standard-setting processes under a single independent drug controller in alignment with the Drugs and Cosmetics ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Discover how the U.S. healthcare system has evolved over the years in terms of treatment outcomes, appropriate treatment, patient safety & preventive services.
In the fast-evolving world of artificial intelligence and machine learning, the importance of rigorous quality assurance ...
The FDA’s restraints on food ingredients are limited and relatively feeble, especially compared with those in Europe, a KFF Health News examination found.
Archimedic has unveiled OpenQMS, a free, web-based platform designed to help medtech companies efficiently manage Quality ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
THE Food and Drug Administration (FDA) has launched an online application process for Certificate of Medical Device ...
DexCom received a warning letter from the Food and Drug Administration following inspections of two of its plants.
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz. facilities and is working on a written response.
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback